References
- 1. Hallworth MJ. The 70% claim - what is the evidence base? Ann Clin Biochem 2011; 48: 487-8. DOI: 10.1258/acb.2011.011177
- 2. Englezopoulou A, Kechagia M, Chatzikiriakou R, Kanellopoulou M, Valenti M, Masedu F. Pre-Analytical Errors as Quality Indicators in Clinical Laboratory. Austin J Public Health Epidemiol. 2016;3(5):1-8.
- 3. Lippi G, Mattiuzzi C, Favaloro EJ. Pre-analytical variability and quality of diagnosis testing. Looking at the moon and gazing beyond the finger. N Z J Med Lab Sci. 2015; 69:4-8.
- 4. Plebani M. Errors in Clinical Laboratories or Errors in Laboratory Medicine? Clin Chem Lab Med. 2006;44(6):750-9. DOI: 10.1515/CCLM.2006.123
- 5. Gosselin RC, Marlar RA. Preanalytical Variables in Coagulation Testing: Setting the Stage for Accurate Results. Semin Thromb Hemost. 2019;45(5):433-48. DOI: 10.1055/s-0039-1692700
- 6. Favaloro EJ, (Addock) Funk DM, Lippi G. Pre-analytical Variables in Coagulation Testing Associated with Diagnostic Errors in Hemostasis. Labmedicine. 2010; 43(2):1-10. DOI: 10.1309/LM749BQETKYPYPVM
- 7. Austin M, Ferrell C, Reyes M. Do elevated hematocrits prolong the PT/aPTT? Clin Lab Sci. 2013; 26:89-94. DOI: 10.29074/ascls.26.2.89
- 8. CLSI. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays: Approved Guideline. 5th ed. CLSI document H21-A5. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
- 9. Marlar RA, Potts RM, Marlar AA. Effect on Routine and Special Coagulation Testing Values of Citrate Anticoagulant Adjustment in Patients with High Hematocrit Values. Am J Clin Pathol. 2006;126: 400-5. DOI: 10.1309/RRQKT2JEYV33D19D
- 10. Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-24. DOI: 10.1182/blood-2013-06-508325
- 11. Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M. British Committee for Standards in Haematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 2013; 35(01):1-13. DOI: 10.1111/ijlh.12004
- 12. Lippi G, Favaloro EJ. Preanalytical Issues in Hemostasis and Thrombosis Testing. Chapter 2. Lippi G, Favaloro EJ. (eds.), Hemostasis and Thrombosis: Methods and Protocols, © Springer Science+Business Media LLC, 2017;1646: 47. DOI: 10.1007/978-1-4939-7196-1
- 13. Salvagno GL, Lippi G, Bassi A, Poli G, Guidi GC. Prevalence and Type of Pre-Analytical Problems for Inpatients Samples in Coagulation Laboratory. J Eval Clin Pract. 2008;14(2):351-3. DOI: 10.1111/j.1365-2753.2007.00875.x
- 14. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med. 2006;44(4):358-65. DOI: 10.1515/CCLM.2006.073
- 15. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med. 2007; 45:720-7. DOI: 10.1515/CCLM.2007.167
- 16. CLSI. Collection of Diagnostic Venous Blood Specimens. 7th ed. Standard GP41. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
- 17. Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. Am J Clin Pathol. 1998; 109 (05): 595-9. DOI: 10.1093/ajcp/109.5.595
- 18. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2009; 12: 444-54. DOI: 10.1017/S1368980008002401
- 19. Zaninetti C, Klersy C, Scavariello C, Bastia R, Balduini CL, Invernizzi R. Prevalence of Anemia in Hospitalized Internal Medicine Patients: Correlations with Comorbidities and Length of Hospital Stay. Eur J Intern Med. 2018; 51:11-7. DOI: 10.1016/j. ejim.2017.11.001
- 20. Girelli D, Marchi G, Camaschella C. Anemia in the Elderly. Hemasphere. 2018; 17;2(3): e40. DOI: 10.1097/HS9.0000000000000040
- 21. DeMaeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, et al. Preventing and controlling anaemia through primary health care: a guide for health administrators and programme managers. Geneva, World Health Organization. 1989. Available from https://apps.who.int/iris/handle/10665/39849.
- 22. US Department of Health and Human Services. National Institutes of Health. National Cancer Institute. Common terminology criteria for adverse events (CTCAE). Version 4.0. National Cancer Institute website. Available from https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm. Published May 28, 2009.